SCHEMBL8229145

SCHEMBL8229145

COc1cccc(-c2csc(NC(=O)CCCCCNC(=O)CS)n2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.60
▸ NPC1 O15118 2/20 0.60
▸ RAB9A P51151 2/20 0.60
▸ HTT P42858 2/20 0.60
▸ HPGD P15428 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ HSD17B10 Q99714 1/20 0.60
▸ HDAC1 Q13547 12/20 0.59
▸ HDAC6 Q9UBN7 11/20 0.59
▸ HDAC9 Q9UKV0 10/20 0.59
▸ HDAC3 O15379 9/20 0.59
▸ HDAC2 Q92769 9/20 0.59
▸ HDAC10 Q969S8 9/20 0.59
▸ HDAC8 Q9BY41 9/20 0.59
▸ HDAC4 P56524 7/20 0.59
▸ HDAC7 Q8WUI4 7/20 0.59
▸ HDAC11 Q96DB2 7/20 0.59
▸ HDAC5 Q9UQL6 7/20 0.59
▸ MEN1 O00255 3/20 0.57
▸ KMT2A Q03164 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13213519 0.89 HDAC1 (0.69) ALDH1A1NPC1RAB9ASMN1; SMN2HDAC1
SCHEMBL8230787 0.85 HDAC1 (0.64) ALDH1A1NPC1RAB9AHPGDSMN1; SMN2
SCHEMBL21586315 0.79 ALDH1A1 (0.74) ALDH1A1NPC1RAB9AHTTHPGD
SCHEMBL8272150 0.79 HDAC1 (0.65) HDAC1HDAC6HDAC9HDAC3HDAC2
SCHEMBL10809915 0.77 MEN1 (0.86) ALDH1A1NPC1RAB9AHTTHPGD
SCHEMBL10923238 0.77 ALDH1A1 (0.83) ALDH1A1NPC1RAB9AHTTHPGD
SCHEMBL24359677 0.77 HDAC1 (0.78) NPC1RAB9AHDAC1HDAC6HDAC9
SCHEMBL8227619 0.77 HDAC1 (0.61) SMN1; SMN2HDAC1HDAC6HDAC9HDAC3
SCHEMBL5999791 0.76 HDAC1 (0.65) ALDH1A1NPC1RAB9ASMN1; SMN2HDAC1
SCHEMBL24359341 0.76 HDAC1 (0.77) ALDH1A1NPC1RAB9AHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8653278-B2 Isoform selective HDAC inhibitors GEORGETOWN UNIVERSITY (US) 2014-02-18 — — US disclosed
US-8653278-B2 Isoform selective HDAC inhibitors GEORGETOWN UNIVERSITY (US) 2014-02-18 — — US disclosed
US-20100196502-A1 Isoform Selective HDAC Inhibitors GEORGETOWN UNIVERSITY (US) 2010-08-05 — — US disclosed
US-20100196502-A1 Isoform Selective HDAC Inhibitors GEORGETOWN UNIVERSITY (US) 2010-08-05 — — US disclosed
WO-2008019025-A2 ISOFORM-SELECTIVE HDAC INHIBITORS GEORGETOWN UNIVERSITY (US) 2008-02-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100196502-A1 Isoform Selective HDAC Inhibitors HDAC5, HDAC6, HDAC3 ALDH1A1 1257/4885NPC1 1381/4885RAB9A 2546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback